Evidence map›Paper›PMID 31965585›Full record

ReviewJournal of orthopaedic research : official publication of the Orthopaedic Research Society2020

New developments and future challenges in prevention, diagnosis, and treatment of prosthetic joint infection.

Benjamin F Ricciardi, Gowrishankar Muthukrishnan, Elysia A Masters, Nathan Kaplan, John L Daiss, Edward M Schwarz

Open access · greenAbstract readReview
In one paragraph

Review in Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Immune Response to Persistent Staphyloccocus Aureus Periprosthetic Joint Infection in a Mouse Tibial Implant Model.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Benjamin F RicciardiDepartment of Orthopaedics, Center for Musculoskeletal Research, University of Rochester School of Medicine, Rochester, New York.ORCID 0000-0001-9384-4840
Gowrishankar MuthukrishnanDepartment of Orthopaedics, Center for Musculoskeletal Research, University of Rochester School of Medicine, Rochester, New York.ORCID 0000-0001-7521-6154
Elysia A MastersDepartment of Orthopaedics, Center for Musculoskeletal Research, University of Rochester School of Medicine, Rochester, New York.
Nathan KaplanDepartment of Orthopaedics, Center for Musculoskeletal Research, University of Rochester School of Medicine, Rochester, New York.
John L DaissDepartment of Orthopaedics, Center for Musculoskeletal Research, University of Rochester School of Medicine, Rochester, New York.
Edward M SchwarzDepartment of Orthopaedics, Center for Musculoskeletal Research, University of Rochester School of Medicine, Rochester, New York.ORCID 0000-0002-4854-9698
University of Rochester · US

Funding

Project 2: Defining the Protective vs. Susceptible Immune Proteome of S. aureus OsteomyelitisP50AR072000 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2017 to 2026
$13.6M
Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)P30AR069655 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2016 to 2026
$7.8M
NIAMS NIH HHS P30 AR069655NIAMS NIH HHS P50 AR072000
6 · The paper itself

Abstract

Prosthetic joint infection (PJI) is a devastating complication that results in substantial costs to society and patient morbidity. Advancements in our knowledge of this condition have focused on prevention, diagnosis, and treatment, in order to reduce rates of PJI and improve patient outcomes. Preventive measures such as optimization of patient comorbidities, and perioperative antibiotic usage are intensive areas of current clinical research to reduce the rate of PJI. Improved diagnostic tests such as synovial fluid (SF) α-defensin enzyme-linked immunosorbent assay, and nucleic acid-based tests for serum, SF, and tissue cultures, have improved diagnostic accuracy and organism identification. Increasing the diversity of available antibiotic therapy, immunotherapy, and alternative implant coatings remain promising treatments to improve infection eradication in the setting of PJI.

Indexed as

Arthritis, InfectiousHumansProsthesis-Related Infectionsosteomyelitisprosthetic joint infectionrevision total joint replacementtotal joint replacement

Identifiers

PMID31965585
PMCPMC7304545
OpenAlexW3001845845

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.